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Objective: Mild obesity may have a protective effect against some diseases, termed an “obesity paradox.” This study
examined the effect of body mass index (Kg/m2 BMI) on surgical 30-day morbidity and mortality in patients undergoing
vascular surgical procedures.
Methods: As part of the National Surgical Quality Improvement Program (NSQIP), demographic and clinical risk
variables, mortality, and 22 defined complications (morbidity) were obtained over three years from vascular services at 14
medical centers. At each medical center, patients from the operative schedule were prospectively and systematically
enrolled according to NSQIP protocols. Outcomes and risk variables were compared across NIH-defined obesity classes
(underweight [BMI<18.5], normal [18.5<BMI<25], overweight [25<BMI<30], obese I [30<BMI<35], obese II
[35<BMI<40], and obese III [BMI>40]) using analysis of variance and means comparisons. Logistic regression was
used to control for other risk factors.
Results: Vascular procedures in 7,543 patients included lower extremity revascularization (24.6%), aneurysm repair
(17.4%), cerebrovascular procedures (17.3%), amputations (9.4%), and “other” procedures (31.3%). In the entire cohort,
there were 1,659 (22.0%) patients with complications and 295 (3.9%) deaths. Risk factors of hypertension and diabetes
increased with BMI (analysis of variance [ANOVA] P < .05) as expected; smoking, disseminated cancer, and stroke
decreased (ANOVA P < .01). Twenty other risk factors, as well as mortality and morbidity, had “U” or “J”-shaped
distributions with the highest incidence in underweight and/or obese class III extremes but reduced minimums in
overweight or obese I classes (ANOVA P < .05). After controlling for age, gender, and operation type, mortality risk
remained lowest in obese class I patients (Odds ratio [OR] 0.63, P .023) while morbidity risk was highest in obese class
III patients (OR 1.70, P  .0003), due to wound infection, thromboembolism, and renal complications.
Conclusion: Underweight patients have poorer outcomes and class III obesity is associated with increased morbidity.
Mildly obese patients have reduced co-morbid illness, surprisingly even less than normal-class patients, with correspond-
ingly reduced mortality. Mild obesity is not a risk factor for 30-day outcomes after vascular surgery and confers an
advantage. (J Vasc Surg 2009;49:140-7.)Obesity, which is widespread and increasing in the
United States,1 has been associated with the development
of diabetes mellitus, hypertension,2 cardiovascular disease,3
heart failure,4 and death from all causes.5 Despite the
association of obesity with the development of chronic
disease states that lead to early mortality, a number of
recent studies have described an “obesity paradox,” in
which an improved survival has been observed in obese
patients with heart failure,6,7 those undergoing coronary
bypass,8 and obesity was found to be a significant factor
associated with smaller infarct size following myocardial
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140infarction.9 These reports raise the question as to what
effect obesity has on short-term outcome in patients under-
going vascular surgery procedures.
To date, there are few studies that specifically address
the effect of obesity on outcome in vascular surgery pa-
tients. A small study by Nicholson et al reported that
obesity was not a risk factor in vascular reconstructive
surgery.10 Gurm et al likewise found no association be-
tween body mass index (Kg/m2 BMI) and short-term
outcomes after carotid stenting.11 Chang et al found that
obesity was not associated with increased infection rates
after lower extremity revascularizations,12 althoughNam et
al reported a higher risk of wound complications with
infra-inguinal venous bypass grafting in obese patients.13 In
patients with thigh arteriovenous shunts, obesity (BMI 
30) has been associated with increased access failure, and
thus more operations were required in obese patients.14
Finally, in patients with peripheral vascular disease requir-
ing lower extremity amputation, obesity did not predict
poorer prognosis.15
The purpose of this study was to examine the relation-
ship between BMI obesity class as defined by National
Institutes of Health (NIH) on surgical 30-day morbidity
and mortality in a large cohort of patients undergoing a
variety of vascular surgery procedures. This studymakes use
of the diverse clinical risk factors and postoperative out-
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provement Program (NSQIP) data set gathered through
the Patient Safety in Surgery Study (PSS).
METHODS
This is a sub-study of data obtained through the PSS
Study. A detailed description of the PSS Study, which used
NSQIPmethodologies, has been reported previously16 and
is summarized here. Data from patients who underwent
major vascular procedures at 14 academic medical centers
participating in the PSS study from fiscal years 2002
through 2004 were analyzed. Each hospital had a risk-
assessment nurse, who prospectively collected preoperative
patient characteristics, clinical risk factors, intraoperative
processes of care, and postoperative adverse occurrences up
to 30 days after the operation. The first 40 operations in
each eight-day cycle were included for data collection.
Follow-up patient information was obtained from paper
and electronic medical records, morbidity and mortality
conference reports, as well as through communication with
patients by letter or telephone after discharge. The nurses
were trained on study definitions, participated in regular
conference calls, and attended annual meetings. Regular
site visits occurred to ensure data reliability. Multiple oper-
ations on the same patient within 30 days were not included
in the analysis. If complications that required a reoperation
occurred, they were recorded but the reoperation was not
included as a second index case. We proposed this second-
ary analysis of the PSS study database to the PSS Study
Publications Committee and were given the analytical re-
sults.
Measures and statistical analyses. BMI values were
calculated for each patient and categorized according to the
NIH obesity categories which are listed in Table I.17 Op-
Table I. Procedure groups used in the study with their











revascularization 1852 (24.6%) 70 (3.8%) 573 (30.9%)
AAA – iliac aneurysm 1316 (17.4%) 55 (4.2%) 291 (22.1%)
Cerebrovascular 1307 (17.4%) 14 (1.1%) 106 (8.1%)
Amputation 712 (9.4%) 68 (9.6%) 223 (31.3%)
Mesenteric/renal
revascularization 110 (1.5%) 5 (4.5%) 38 (34.6%)
Vascular access 80 (1.1%) 3 (3.8%) 11 (13.8%)
Otherb 2166 (28.6%) 80 (3.7%) 419 (19.3%)
Total 7543 (100%) 295 (3.9%) 1661 (22.0%)
AAA, abdominal aortic aneurysm.
*30-day mortality and morbidity varied significantly by procedure group
(ANOVA P  .05).
aMorbidity was defined as one or more of the 22 NSQIP defined complica-
tions.
bOther procedures performed on vascular surgery services at 14 academic
medical centers.eration complexity was measured using the maximum ofthe work relative value units (WRVUs)18 associated with
the procedure codes recorded for the surgery. One of the
investigators (E.D.E.), a vascular surgeon, grouped the
procedures based on the primary procedure by Current
Procedural Terminology (CPT) code. The primary proce-
dure codes included in each group are listed in the Appen-
dix (online only).
Analysis of variance (ANOVA) of morbidity and mor-
tality across obesity classes was performed. Outcome rates
for each obesity class were further compared to normal-
class patients using the Bonferroni test for multiple com-
parisons of means. Similar stratification and comparison
was performed on the demographic, preoperative and peri-
operative variables. Complications were categorized into
nine groups and similar analyses performed.
Multivariable logistic regression was used to assess the
odds ratios for the 30-day outcomes with normal class used
as the reference. The regressions were performed with
obesity classes alone as predictor variables and then re-
peated with the inclusion of age, gender, procedure group,
and WRVUs as controls.
RESULTS
The PSS study database included 8,706 vascular sur-
gery patients, of which 1,163 did not have heights or
weights recorded, leaving 7,543 for BMI calculation and
analysis. A broad spectrum of cases performed on vascular
surgery services was included in the study and significant
variation in mortality and morbidity occurred between the
procedure groups (ANOVA P  .05, Table I). Significant
variation occurred in the distribution of patients by obesity
class across the different procedure groups (2 P  .0001,
Table II). The median patient obesity class was overweight,
and over 25% of the patients were in obese classes I through
III. At the extremes, 345 (4.6%) of the patients were
underweight and 285 (3.8%) were obese class III, or mor-
bidly obese.
Patient characteristics by obesity class. The majority
of underweight and obese class III patients were female
(Bonferroni P  .05 relative to normal-class, Table III)
while overweight and obese I patients were more often
male (Bonferroni P .05). The age at operation decreased
significantly with increasing obesity (Bonferroni P  .05).
The incidence of medically-treated diabetes and hyperten-
sion increased with obesity class as expected, as did dyspnea
at rest or with mild exertion (ANOVA P  .05). However
the relationship with cardiovascular disease (CVD, as mea-
sured by a history of congestive heart failure, myocardial
infarction, angina, prior cardiac operation, or angioplasty) was
less pronounced.Overweight patients had significantly higher
CVD than normal class patients (Bonferroni P  .05). In
contrast to these factors, the risk factors of smoking, pack-
years smoked, history of stroke, disseminated cancer, re-
duced white blood cell count, and recent weight loss10%
tended to decrease with increasing BMI (ANOVA P .05
except for disseminated cancer). Twelve other risk factors
that varied significantly with obesity class had a “U” shaped
distribution with the lowest risk in overweight or obese I
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Primary procedure group
(n, % of total)














(1852, 24.6%) 124 (6.7%) 677 (36.6%) 634 (34.2%) 267 (14.4%) 88 (4.8%) 62 (3.4%)
AAA – iliac aneurysm (1316,
17.4%) 43 (3.3%) 401 (30.5%) 524 (39.8%) 253 (19.2%) 67 (5.1%) 28 (2.1%)
Cerebrovascular (1307, 17.4%) 32 (2.4%) 400 (30.6%) 537 (41.1%) 220 (16.8%) 78 (6.0%) 40 (3.1%)
Amputation (712, 9.4%) 61 (8.6%) 256 (36.0%) 206 (28.9%) 106 (14.9%) 53 (7.4%) 30 (4.2%)
Mesenteric/renal
revascularization (110, 1.5%) 9 (8.2%) 50 (45.5%) 30 (27.3%) 15 (13.6%) 5 (4.6%) 1 (0.9%)
Vascular access (80, 1.1%) 8 (10.0%) 25 (31.3%) 21 (26.3%) 14 (17.5%) 7 (8.8%) 5 (6.3%)
Other (2166, 28.7%) 68 (3.1%) 812 (37.5%) 679 (31.4%) 354 (16.3%) 134 (6.2%) 119 (5.5%)
Total (7543, 100%) 345 (4.6%) 2621 (34.8%) 2631 (34.9%) 1229 (16.3%) 432 (5.7%) 285 (3.8%)*The distribution of patients across obesity classes varied significantly by procedure group (Chi-squared P  .0001).Table III. Patient characteristics by obesity class
Patient characteristics Underweight Normal (reference) Overweight Obese I Obese II Obese III
No. of cases 345 2621 2631 1229 432 285
Demographic factors
Male (%)* 47.8L 56.2 67.4H 61.8H 51.2 42.8L
Mean age (years)* 65.5 66.2 66.1 63.5L 60.8L 57.9L
General risk factors
ASA class 4 or 5 (%)* 21.8 15.7 14.7 13.3 13.9 18.6
Emergent (%)* 13.9 12.4 10.7 10.7 11.6 19.3H
Medically treated diabetic (%)* 19.4 20.0 26.5H 35.8H 38.4H 48.1H
Partial or full functional dependence (%)* 24.9H 14.7 11.7 9.8L 17.5 16.0
Dyspnea at rest or with moderate exertion (%)* 26.1 20.0 20.6 25.7H 26.6H 33.7H
Pulmonary risk factors
COPD (%)* 17.7H 11.6 10.6 10.8 10.4 11.9
Current smoker (%)* 48.4H 32.2 29.4 27.5L 28.5 27.4
Mean pack years smoked* 34.8H 28.4 30.5 28.9 27.3 22.9
Cardiovascular risk factors
Hypertensive req. med. (%)* 69.6 68.9 73.9H 78.0H 75.5 79.3H
History of CVDa (%)* 31.6 33.6 38.8H 38.2 36.6 34.0
History of PVDb (%)* 60.0H 42.4 36.6L 37.3 37.5 40.4
Central nervous system risk factor
History of strokec (%)* 23.5 21.5 21.7 19.5 17.6 15.8
Hepatic/renal/gastrointestinal risk factors
On dialysis (%)* 16.2H 8.6 6.5 6.1 11.6 9.8
Renal dysfunctiond (%) 32.8 33.5 35.8 36.7 36.8 34.7
Hepatic dysfunctione (%)* 50.4H 39.1 35.4 36.8 33.6 39.6
Bleeding disorder (%)* 9.6 10.4 7.8L 8.2 8.6 8.1
Nutritional/immune/other risk factors
Albumin (Mean)* 3.27L 3.56 3.66H 3.67H 3.51 3.44
Disseminated cancer (%) 1.4 0.7 0.8 0.5 0.2 0.4
Weight loss 10% (%)* 14.8H 4.0 1.4L 0.7L 0.7L 0.4L
WBC  4.5 (%) 3.0 5.2 4.7 4.4 3.1 2.9
Infectious risk factors
Open wound or infection (%)* 36.5H 22.0 19.4 20.3 24.8 28.8
Sepsis (%)* 4.7 2.6 2.3 2.2 5.6H 4.6
WBC  11.0 (%)* 28.1H 17.0 15.7 17.7 18.2 26.1H
AAA, abdominal aortic aneurysm; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; PVD, peripheral vascular disease;WBC, white
blood cell count.
Significant variance in risk factor across obesity classes, ANOVA P  .05.
HObesity class rate higher than normal-class based on a Bonferroni comparison of means, P  .05.
LObesity class rate lower than normal based on a Bonferroni comparison of means, P  .05.
aHistory of cardiovascular disease includes congestive heart failure, angina, myocardial infarction, prior cardiac operation, or angioplasty.
bHistory of peripheral vascular disease includes prior peripheral vascular surgery, rest pain, or gangrene.
cHistory of stroke includes transient ischemic attack or cerebrovascular accident with or without neurologic compromise.
dRenal dysfunction includes blood urea nitrogen (BUN)  40 or creatinine  1.2.
eHepatic dysfunction includes alkaline phosphatase  125, bilirubin  1.0 or serum glutamic-oxaloacetic transaminase (SGOT)  40.
f mea
of me
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weight or class III obese patients. These included func-
tional dependence, preoperative sepsis, and ASA class, the
top three risk factors for vascular surgery 30-day mortality
in the 2008 American College of Surgeons NSQIP report
to sites.19
Intraoperative factors. Themean operation length of
time did not vary significantly by obesity class but complex-
ity (measured by the work RVUs of the primary procedure)
and wound class did (ANOVA P  .05, Table IV). Obese
class III patients had significantly less complex operations
(Bonferroni P .05) than normal class patients but similar
operative durations and significantly more contaminated or
dirty wounds (Bonferroni P  .05).
Outcomes. The 30-day mortality rates by obesity class
demonstrate a reverse-“J” shape with the highest values oc-
curring in the underweight and normal class patients
(ANOVA P  .05, Table V). Obese I patients had less
mortality than normal class patients (Bonferroni P  .05).
The 30-day composite morbidity distribution was “U”
shaped with higher levels of complications in the under-
weight and obese class-III extremes (ANOVA P  .05).
The odds ratios for morbidity and mortality, without con-
trols, follow the rate distributions; reverse–“J” for mortality
and “U” shape for morbidity: both overweight and obese
class-I patients have significant reductions in risk of mortal-
ity and underweight and obese class III patients have
increased risk of morbidity (P .05, Fig). When controlled
for age, gender, procedure group, and work RVUs, over-
weight through obese class III patients still had reduced
risk for mortality, significantly so for obese class I patients
(P  .05). Under the same controls morbidity risks in-
creased for obese classes I to III with obese class III patients
at significantly higher risk of morbidity (P  .05). When
the twenty-two specific complications that made up the
composite morbidity definition were grouped into eight
composite categories, three of the unadjusted composite
rates varied significantly (ANOVA P  0.05) by obesity
class: respiratory complications, wound infection, and
thromboembolism. When controlled for age, gender, pro-
cedure group, and work RVUs, obese class I to III patients
had significantly increased risk of urinary tract complica-
tions and wound infection. Obese class III patients also had
increased risk of thromboembolism. Overweight patients,
however, had a significantly reduced risk for respiratory
Table IV. Intraoperative variables by obesity class
Intraoperative variable Underweig
No. of cases 345
Complexity (mean primary procedure work RVUs)* 18.8
Operation duration (mean hrs.) 3.08
Wound class contaminated or dirty/infected (%)* 15.1H
Packed red blood cells transfused (mean units) 0.88
*Significant variance in variable across obesity classes, ANOVA P  .05.
LObesity class lower than normal class based on a Bonferroni comparison o
HObesity class higher than normal class based on a Bonferroni comparisoncomplications.DISCUSSION
Obesity has reached epidemic proportions in the
United States with far reaching adverse implications con-
cerning the overall health status of the population.1 In the
current vascular surgery study, the majority of patients were
overweight or obese, results that are in line with national
trends. Additionally, most preoperative risk factors, intra-
operative factors, and 30-day outcomes measured in this
study varied significantly by obesity class. These findings
indicate the complexity of the clinical interactions associ-
ated with a single variable, BMI.
The current study supports the well known increased
risk of hypertension and diabetes as BMI increases. The
incidence of cardiovascular disease, however, did not cor-
relate linearly with increased BMI. Rather, the highest
incidence was noted in overweight patients. The reason for
this finding is not clear. Interestingly, most risk factors
demonstrated a distribution across obesity classes following
a “U” shaped curve with higher risk factors at the under-
weight and obese class III extremes and minimum risk in
the overweight or obese I classes – not in the normal weight
class. These factors include the American Society of Anesthe-
siologists physical status classification (ASA class), functional
dependence prior to surgery, and preoperative sepsis – the top
three predictors of vascular surgery 30-day mortality accord-
ing to the most recent ACS NSQIP report. What is unclear is
why mildly obese patients should have such reduced comor-
bid risk factors. The comorbid risks were not included as
controls in our analysis due to uncertainty whether these
factors were a result of a patient’s weight status or contributed
to their weight status. We controlled for age and gender
because they are not caused by obesity. We also controlled for
the procedure variables in an attempt to control for presenta-
tion bias in this study of patients admitted for surgery.
Under these controls, obese class I patients demon-
strated a significantly reduced risk for 30-day mortality
compared with normal weight patients, while morbidity
risk was significantly higher in obese class III patients. The
reduction in mortality in obese I patients is likely associated
with the reduced comorbid risks, although again it is not clear
why those risks should be lower in that group. The higher risk
for morbidity in the obese class III patients appears to be
primarily due to an increased rate of wound complications,
renal complications, and thromboembolism. The increased
ormal (reference) Overweight Obese I Obese II Obese III
2621 2631 1229 432 285
18.3 18.8 18.6 17.4 15.9L
2.91 3.03 3.05 2.97 2.91
9.2 8.3 9.1 12.5 15.8H
0.87 0.75 0.83 0.59 0.79
ns, P  .05.
ans, P  .05.ht Nrate of wound complications can be explained by the need for
st req
d post
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poor blood supply to the adipose tissue.
Other studies have also investigated the effect of obesity
on surgical outcome. Two studies in general surgery patients
showed no increase inmorbidity related to obesity.20,21 Stud-
ies in the cardiovascular arena have largely focused on
coronary artery bypass grafting (CABG) and have found
mixed results.22-35 Jin et al postulated that these mixed
results were due to different BMI-class cut points and
sample sizes. However, what is intriguing about Jin’s study
was the finding of reduced mortality in mildly obese pa-
tients.36 Similarly, Romero-Corral, in a meta-analytical re-
view, found that overweight CAD patients have the lowest
risk of cardiovascular and total mortality.37 These data
support our findings of reduced mortality in mildly obese
patients, while again not clarifying the mechanism.
In addition, while it is widely accepted that obesity
Table V. Outcome rates by obesity class
Outcome Underweight Normal (re
No. of cases 345 2621
Mortality %* 6.96 4.
Morbidity %* 28.1 22.
Return to operating room %* 24.1H 17.
aSystemic infection % 4.1 2.
Odds ratio with control 1.5 ref.
bRespiratory complication %* 13.6 9.
Odds ratio with control 1.5H ref.
cWound infection %* 4.1 6.
Odds ratio with control 0.5L ref.
dRenal complication % 8.1 6.
Odds ratio with control 1.2 ref.
eCNS complication % 2.0 1.
Odds ratio with control 1.1 ref.
fThromboembolism %* 1.2 1.
Odds ratio with control 1.1 ref.
gCardiac complication % 2.3 2.
Odds ratio with control 0.8 ref.
hOther complication % 6.4 4.
Odds ratio with control 1.3 ref.
CNS, central nervous system.
Complication groups include obesity class odds ratios relative to normal cla
*Significant variance in outcome rates across obesity classes, ANOVA P  .
LObesity class rate lower than normal based on a Bonferroni comparison of m
HObesity class rate higher than normal-class based on a Bonferroni comparis
P  .05.
aSystemic infections included patients with systemic inflammatory response
bRespiratory complications included pneumonia, failure to wean from vent
cWound infection included superficial and deep wound infections, organ/s
dRenal complications included urinary tract infections, progressive renal ins
eCentral nervous system complications included stroke, coma greater than
fThromboembolism included pulmonary embolism and deep venous throm
gCardiac complications include acute myocardial infarction and cardiac arre
hOther complications include failure of a graft, prosthesis or flap failure, anincreases the risk for developing heart disease, a growingnumber of recent reports document a significant survival
benefit for obese patients once they have been diagnosed
with cardiovascular diseases.6-9 This has been termed the
“obesity paradox.” The current study supports this obser-
vation by demonstrating an improved mortality in over-
weight patients and raises the question why overweight or
moderately obese patientsmay have an improvement in short-
term surgical outcomes but be at risk for long-term illnesses
that place themat increased risk formortality at a younger age.
The current study cannot directly address the causes for this
paradox, but a number of hypotheses can be proposed.
One possible explanation for this paradox may be re-
lated to the metabolic activity of adipose tissue. Adipose
tissue, once considered simply a lipid storage depot, is now
known to produce and secrete an increasing range of fac-
tors, collectively termed adipokines.38 For instance, recent
findings have shown that the adipokine adiponectin directly
ce) Overweight Obese I Obese II Obese III
2631 1229 432 285
3.42 2.69L 3.01 3.16
19.7 22.4 23.6 28.1
15.4 16.4 18.3 20.7
2.1 2.6 3.0 2.8
0.9 1.2 1.5 1.6
6.8L 8.5 6.7 6.7
0.8L 1.0 0.9 1.0
6.7 8.1 7.9 13.7H
1.2 1.5H 1.4 2.5H
5.3 6.7 6.9 6.7
1.0 1.4H 1.6H 1.7H
1.6 1.8 1.4 2.1
0.9 1.1 0.9 1.4
1.3 1.0 1.6 3.2H
1.4 1.1 1.8 3.7H
1.9 2.4 1.9 1.8
0.7 1.0 0.8 0.8
3.6 4.4 5.3 6.0
0.9 1.1 1.4 1.6
trolled for age, gender, procedure group and complexity.
or odds ratio significantly less than 1.0 based on the Wald statistic, P .05.
means or odds ratio significantly higher than 1.0 based on the Wald statistic,
ome, sepsis, or septic shock.
at 48 hours postoperatively, or unplanned intubation.
fections, or wound disruptions.
ncy, and acute renal failure.
rs postoperatively, and peripheral nerve injury.
uiring resuscitation.





















bosis.affects signaling in cardiac cells and is beneficial in the
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diac injury.39 Another cytokine produced by adipocytes that
could have a protective effect is resistin.40 Though most
research has focused on its effects on glucose homeostasis,41
resistin also induces in vitro endothelial cell proliferation and
migration.42 Such effects could aid the vascular healing pro-
cess although it has been shown to cause endothelial cell
dysfunction in pig coronary arteries.43
Another possible explanation for an obesity paradox is a
nutritional component resulting in improved outcomes in
patients with mild to moderate obesity. The results in the
current study found that preoperative albumin levels dif-
fered significantly among the BMI groups. The highest
levels were found in the obese class I patients, suggesting
that these patients may have had the “best” preoperative
nutritional status. These patients may, as a result, be better
suited to withstand the stress of starvation and injury in-
duced by an operation.
While the current study has demonstrated a correlation
between moderately increased BMI and improved mortal-
ity, it should be emphasized that this study examined only
the perioperative (30-day) outcome following a vascular sur-
gical procedure. These results cannot and should not be
compared to the long-term effects of obesity on overall health
status, particularly in the relationship of obesity to the devel-
opment of hypertension and diabetes. In fact, as noted, these
conditions were found to increase as BMI increased.
There are obvious limitations to this observational
study. While observations of relationships between risk
factors, obesity class, and outcome can be made, cause and
Fig. Obesity class odds ratios for thirty-day mortality and morbid-
ity relative to normal class patients. Results shown are for obesity
classes alone and with control for age, gender, and the operation.
With control, obese class I patients were at reduced risk of mortal-
ity and morbidly obese patients were at increased risk of morbidity.effect is difficult, if not impossible, to prove. The proceduregroups also encompass many different operations. For ex-
ample, treatment of aneurysm disease includes both open
and endoluminal approaches. Similarly, the category of
“other” is large and includes diverse vascular procedures
such as thrombectomy/embolectomy, venous procedures,
peripheral aneurysm repair, reoperative vascular surgery,
upper extremity bypass, carotid and vertebral bypass/
transposition, and endoluminal angioplasty and stenting.
Additionally, while patients were included in the study in a
systematic prospective fashion, it is a sampling of patients
and did not include all patients undergoing vascular proce-
dures at each institution. The study also did not identify
patients with the metabolic syndrome and did not differen-
tiate between central obesity and peripheral obesity. Such a
study would require waist and hip anthropomorphic mea-
surements.
On the other hand, there are also strengths to the
study. Data collected from 14 different institutions over a
three year period on several thousand patients should elim-
inate many sources of bias and suggests that the findings are
generalizable. The use of the NSQIP methodology, defini-
tions, and nurses also allows confidence that the data from
different institutions is reproducible and comparable. Fur-
thermore, the operations included in the study were inclu-
sive of essentially all vascular procedures and for the patient
cohort as a whole and provides an overall concept of how
BMI relates to outcomes in vascular surgery patients.
Further research to isolate the specific mechanisms for
these findings faces significant challenges. BMI categories
interacted with numerous clinical risk factors in our
study in a non-straight line fashion (“U” or “J” shaped
distributions); indicating complex interdependent, or
multiple independent, interactions. These risk factors
included cardiovascular and peripheral vascular disease,
the indication for vascular surgery, and therefore present-
ing selection bias in vascular surgery studies. Added to
complexity and selection bias challenges, the chronicity of
obesity requires evaluation, possibly starting in infancy.
Effective studies will therefore need to be long term popu-
lation studies including behaviors, obesity status, and clin-
ical interventions including vascular surgery. Further basic
science studies on the humoral and metabolic functions of
adipose tissue should also yield clarification on the impact
of obesity, if any, on the inflammatory cascade and vascular
tissue repair. Lastly, we are intrigued by the potential of a
randomized study of the benefits of nutritional supplemen-
tation to elective surgical patients who have the option of
waiting for surgery. The well known importance of albumin
as a predictor of surgical outcomes and the suggestion in
our data of a relationship with mild obesity make this an
intriguing study. We also postulate an interaction between
BMI, nutrition, glycemic control, and 30-day outcomes
that could be examined.
In summary, the current study found significant benefit
in 30-day mortality in obese class I patients undergoing a
vascular procedure. The mortality reduction in obese I
patients is likely due to the reduced comorbid risk factors in
these patients, but why they would have reduced comorbid
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study. These findings are consistent with other reports that
have also shown improved outcome in obese patients and
coined this as an “obesity paradox.” We have postulated
that these results could be due to differences in the meta-
bolic makeup of obese patients and/or improved nutri-
tional status. It also is possible that other mechanisms may
be the cause of these findings and further studies will be
needed to identify the precise mechanisms responsible.
Significantly higher morbidity was found in obese class III
patients; primarily due to the higher incidence of wound
complications, thromboembolism, and renal complications
in this patient group.
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Dr Angeliki Vouyouka (New York, NY): The paper was very
interesting, but I have a few questions.
From the data that you show us here, the obese class I and the
overweight patients compared to the normal and the underweight,
they appeared to be healthier. They were more likely to be diabetic
and hypertensive; however, they were less likely to be smokers, they
have better ASA risk class, and they were less likely to have COPD.
So do you think that part of your observation reflects some
selection bias among the surgeons, since they were all elective
cases, and therefore when they had to operate on obese patients
they chose the ones that they were in best health as compared to
the rest of them?
Secondly, you have insinuated the answer of this question, but
for better clarification, what percentage of the obese patients had
endovascular procedures, as compared to normal weight and un-
derweight?
And thirdly, again, in the same spirit with the first question, in
this data the obese patients, obese class I, and the overweight, they
did have higher albumin levels, a fact that again perhaps reflects
some selection bias. Do we know patients with low preoperative
serum albumin, obese or overweight, how they did compare to the
ones with high levels of serum albumin?
I want again to thank the committee for the privilege to
discuss this very interesting paper.
Dr Eleftherios Xenos: To answer the second question, we
don’t have a breakdown between endovascular versus open repair
of aneurysms. There is a procedure category that was labeled other
and comprised approximately 30% of the patients. It included thedon’t have an exact number of how many people had an endovas-
cular versus open general vascular procedure.
And I agree with the observation that there might very well be
a selection bias where relatively healthy obese subjects were offered
an operation and very sick morbidly obese patients were denied an
operation and that might be partially responsible for what we see.
Dr Martin Veller (Johannesburg, South Africa): Many of the
individuals we treat with a low BMI have such a low BMI as a result
of an underlying chronic disease. Were you in any way able to look
at this in your study? For example, were the serum albumin levels
helpful in differentiating those individuals with a low BMI as a
result of a chronic disease from those with a low BMI without a
chronic disease?
Dr Xenos: Yes, indeed, it does seem that if somebody is
underweight, he’s underweight for a reason. Many of our risk
factors were highest in underweight patients including dissemi-
nated cancer and recent weight loss. There was also a higher
incidence of patients with COPD. There was, however, no single
etiology for being underweight and having chronic disease.
Dr Starros Kakkos (Detroit, MI): Do you think that slightly
overweight people are naturally selected to be more resistant to
trauma or similar conditions, like surgery?
Dr Xenos: I think it is hard to tell. In our study population,
moderate overweight and obese I type patients had the least
amount of risk factors.
Dr Kakkos: Probably because the definition and grades of
obesity are based on survival statistics.
Dr Xenos: Yes, that is true, the patients were stratified accord-
ing to their BMI, not survival statistics.
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January 2009147.e1 Davenport et alAppendix, online only. Procedure grouping by primary CPT code
Procedure group Primary procedure CPT codes included
Amputation 27290, 27295, 27590, 27591, 27592, 27594, 27598, 27880, 27881, 27882, 27884, 27886,
27888, 27889, 28880, 28805, 28810, 28820, 28825
Abdominal aortic/iliac aneurysm 34800, 34802, 34803, 34804, 34805, 34808, 34825, 34900, 34808, 34812, 34813, 34820,
34826, 34833, 34834, 34830, 34831, 34832, 35081, 35082, 35091, 35092, 35102,
35103, 35131, 35132
Lower extremity revascularization 35556, 35566, 35571, 35583, 35585, 35587, 35656, 35666, 35671, 35331, 35351, 35355,
35361, 35363, 35521, 35533, 35537, 35538, 35539, 35540, 35548, 35549, 35551,
35558, 35565, 35621, 35623, 35646, 35647, 35651, 35654, 35661, 35663, 35665,
34201, 34203, 35302, 35303, 35304, 35305, 35306, 35371, 35372, 35875, 35876,
35452, 35454, 35456, 35459, 35470, 35472, 35473, 35474, 35481, 35482, 35483,
35485, 35491, 35492, 35493, 35495
Mesenteric-renal revascularization 35341, 35531, 35536, 35560, 35631, 35636, 35697, 35111, 35112, 35121, 35122, 35450,
35471, 35480, 35490
Cerebrovascular 35301, 35390, 35501, 35601, 35001, 35002, 35005, 35201, 35231, 35261, 35691, 35693,
35694, 35695
Vascular access 36825, 36830, 36818, 36819, 36820, 36821
Other All other primary CPT codes from procedures performed on the vascular surgery service at 14
academic medical centers (197 CPT Codes).
-
